MedPath

I3 Pharmaceuticals, LLC

I3 Pharmaceuticals, LLC logo
🇺🇸United States
Ownership
Private
Established
2015-01-01
Employees
51
Market Cap
-
Website
https://www.i3pharmaceuticals.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

8

FDA:8

Drug Approvals

Guanfacine

Approval Date
Oct 11, 2023
FDA

Posaconazole

Approval Date
Aug 30, 2023
FDA

Maraviroc

Approval Date
Aug 18, 2023
FDA

Ramelteon

Approval Date
Apr 28, 2023
FDA

Selegiline Hydrochloride

Approval Date
Jan 11, 2023
FDA

RANOLAZINE

Approval Date
May 4, 2022
FDA

CHLORZOXAZONE

Approval Date
Nov 10, 2020
FDA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.